Clinical Trial Update: Inhaled Treatment for Bronchopulmonary Dysplasia [Phase 1]

View source ↗

Summary

A Phase 1 inhaled treatment trial for bronchopulmonary dysplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: WITHDRAWN